Skip to main content
Premium Trial:

Request an Annual Quote

CombiMatrix, Furuno Sign Microarray Synthesizer Development Deal

NEW YORK, Aug. 9 (GenomeWeb News) - CombiMatrix said today that it has entered into a multi-year strategic alliance with Furuno Electric to design, engineer, and build CombiMatrix's Bench-Top DNA Microarray Synthesizer for its CustomArray microarrays.

 

Under the deal, Hyogo, Japan-based Furuno will pay CombiMatrix an initial fee of $1 million, as well as development and milestones payments. CombiMatrix and Furuno will co-develop a commercial Bench-Top Synthesizer instrument that will synthesize DNA microarrays at core facilities, pharmaceutical and biotech research sites, and academic microarray centers, said CombiMatrix.

 

Additional terms of the arrangement were not disclosed.

 

The Scan

Review of Approval Process

Stat News reports the Department for Health and Human Services' Office of the Inspector General is to investigate FDA's approval of Biogen's Alzheimer's disease drug.

Not Quite Right

A new analysis has found hundreds of studies with incorrect nucleotide sequences reported in their methods, according to Nature News.

CRISPR and mRNA Together

Time magazine reports on the use of mRNA to deliver CRISPR machinery.

Nature Papers Present Smartphone Platform for DNA Diagnosis of Malaria, Mouse Lines for Epigenomic Editing

In Nature this week: a low-cost tool to detect infectious diseases like malaria, and more.